BE905737A - Composition pharmaceutique effervescente a activite analgesique. - Google Patents

Composition pharmaceutique effervescente a activite analgesique.

Info

Publication number
BE905737A
BE905737A BE0/217397A BE217397A BE905737A BE 905737 A BE905737 A BE 905737A BE 0/217397 A BE0/217397 A BE 0/217397A BE 217397 A BE217397 A BE 217397A BE 905737 A BE905737 A BE 905737A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
analgesic activity
effervescent pharmaceutical
effervescent
sodium
Prior art date
Application number
BE0/217397A
Other languages
English (en)
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Luigi Vigano
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BE905737A publication Critical patent/BE905737A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Il est décrit une composition effervescente formée de Ibuprofène 9-17 % p/p, Arginine 17-33% p/p, Bicarbonate de sodium ou de potassium 20-35% p/p, Bitartrate de sodium 25-40% p/p. Une telle composition est utile pour des préparations pharmaceutique sous la forme de comprimés ou de granulés effervescents.
BE0/217397A 1985-11-12 1986-11-12 Composition pharmaceutique effervescente a activite analgesique. BE905737A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8522800A IT1209667B (it) 1985-11-12 1985-11-12 Composizione effeverscente adattivita' analgesica.

Publications (1)

Publication Number Publication Date
BE905737A true BE905737A (fr) 1987-05-12

Family

ID=11200569

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217397A BE905737A (fr) 1985-11-12 1986-11-12 Composition pharmaceutique effervescente a activite analgesique.

Country Status (16)

Country Link
US (1) US4689218A (fr)
JP (1) JPH0761941B2 (fr)
AT (1) AT395372B (fr)
AU (1) AU580516B2 (fr)
BE (1) BE905737A (fr)
CA (1) CA1276113C (fr)
CH (1) CH674934A5 (fr)
DE (1) DE3638414C2 (fr)
FR (1) FR2590893B1 (fr)
GB (1) GB2189994B (fr)
GR (1) GR862697B (fr)
IE (1) IE59055B1 (fr)
IT (1) IT1209667B (fr)
MX (1) MX9203170A (fr)
NL (1) NL193307C (fr)
ZA (1) ZA868529B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
CH677606A5 (fr) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1266583B1 (it) * 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
US5362410A (en) * 1993-09-13 1994-11-08 Mobil Oil Corporation Multifunctional ashless dispersants
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US7687542B2 (en) * 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
US20060013896A1 (en) * 1996-05-17 2006-01-19 Giorgio Reiner Methods of treating acute pain using diclofenac
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
DE19800812C2 (de) * 1998-01-12 2000-05-11 Juergen C Froelich Verbesserte orale Darreichungsformen von L-Arginin-HCl
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20020099037A1 (en) * 2001-01-19 2002-07-25 Akpharma, Inc. Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Phoenix Labs Unlimited Company Effervescent oral opiate dosage form
CA2548915C (fr) * 2003-12-31 2012-10-16 Cima Labs Inc. Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
TWI376242B (en) * 2004-06-29 2012-11-11 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
US7700125B2 (en) * 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
JP2009535409A (ja) * 2006-05-03 2009-10-01 コーワ ファーマシューティカルズ アメリカ，インコーポレイティド 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
EP1905428A1 (fr) 2006-09-26 2008-04-02 Losan Pharma GmbH Comprimé effervescent d'une désintégration rapide et procès pour la preparation
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
DE102008055745B4 (de) 2008-11-04 2019-08-01 Roma Kg Lamellenführungsbolzen einer Lamelle einer Gebäudeöffnungsbeschattungsvorrichtung und Gebäudeöffnungsbeschattungsvorrichtung
JP2010270111A (ja) * 2009-04-21 2010-12-02 Taisho Pharmaceutical Co Ltd アルギニン含有錠剤
MX2010004974A (es) 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
WO2015117987A1 (fr) 2014-02-05 2015-08-13 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulations effervescentes comprenant de l'ibuprofène et de la n-acétylcystéine
EP2913049B1 (fr) 2014-02-27 2016-11-30 Galenicum Health S.L. Compositions pharmaceutiques stables
CN115504850B (zh) 2021-06-07 2025-05-23 河北中化滏恒股份有限公司 1,4－二甲基萘的制造方法
TR2022014503A2 (tr) * 2022-09-20 2022-10-21 Ahmet Melikoglu Yaraların İyileşmesinde Kullanılmak Üzere L-Arjinin İçeren Kompozisyon
GR1010732B (el) * 2023-06-02 2024-07-25 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447988A (en) * 1973-04-03 1976-09-02 Orsymonde Pharmaceutical compositions
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AT371338B (de) * 1979-10-30 1983-06-27 Gergely Gerhard Reinigungstablette fuer zahnprothesen
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
CA1209040A (fr) * 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
GB2148117B (en) * 1983-09-28 1987-10-21 Gergely Gerhard An effervescent composition suitable for effervescent tablets
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
GB2174004B (en) * 1985-04-23 1988-11-30 American Cyanamid Co Pharmaceutical tablet preparations
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions

Also Published As

Publication number Publication date
FR2590893A1 (fr) 1987-06-05
IE59055B1 (en) 1993-12-15
CH674934A5 (fr) 1990-08-15
FR2590893B1 (fr) 1990-07-13
NL8602870A (nl) 1987-06-01
AT395372B (de) 1992-12-10
NL193307C (nl) 1999-06-02
ZA868529B (en) 1987-07-29
GB8626808D0 (en) 1986-12-10
AU6509886A (en) 1987-05-14
GR862697B (en) 1987-03-10
DE3638414C2 (de) 1996-03-28
JPS62149615A (ja) 1987-07-03
NL193307B (nl) 1999-02-01
IT1209667B (it) 1989-08-30
IE862869L (en) 1987-05-12
AU580516B2 (en) 1989-01-12
ATA296586A (de) 1992-05-15
MX9203170A (es) 1992-07-01
JPH0761941B2 (ja) 1995-07-05
CA1276113C (fr) 1990-11-13
IT8522800A0 (it) 1985-11-12
DE3638414A1 (de) 1987-05-21
GB2189994A (en) 1987-11-11
US4689218A (en) 1987-08-25
GB2189994B (en) 1989-10-11

Similar Documents

Publication Publication Date Title
BE905737A (fr) Composition pharmaceutique effervescente a activite analgesique.
BE1002109A3 (fr) Composition pharmaceutique a activite analgesique.
TNSN97139A1 (fr) Derives d'acides d'arylsulfonylaminohydroxamiques
NO982294L (no) Farmas°ytiske blandinger omfattende flurbiprofen
CA2173328A1 (fr) Inhibiteurs de la protease du vih
NO304372B1 (no) Dobbeltvirkende inhibitorer og farmas°ytiske blandinger inneholdende disse
DZ315A1 (fr) Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant.
EP0201742A3 (en) N-acylpyrrolidine derivatives, processes for preparing them, pharmaceutical composition and use
IT1196033B (it) Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
DE69209323D1 (de) Mehrschichttabletten mit gesteuerter wirkstoffabgabe enthaltend sowohl naproxen als auch naproxen natriumsalz
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
DK342989A (da) Betaendelseshaemmende middel
FR2703249B1 (fr) Composition pharmaceutique ayant une activité analgésique contenant du naproxène.
BR9912010A (pt) Polimorfo de um produto farmacêutico
BR9910445A (pt) Preparação farmacêutica
FR2385398A1 (fr) Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate
IS1885B (is) Þíól afleiður með málmpeptíðasa letjandi virkni, aðferð til framleiðslu þeirra, lyfjaefnablöndur sem innihalda slíkt efnasamband, ásamt notkun á efnasamböndunum til framleiðslu á lyfjum
BE895269A (fr) Sel d'acide (+)-2-(2-fluoro-4-biphenylyl)- propionique, procede pour sa preparation et composition pharmaceutique le contenant
NO306395B1 (no) Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav
FR2556218B1 (fr) Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
GT199900171A (es) Concentrado oral de sertralina.
DK197689A (da) Pyridazinderivater
WO1998038994A3 (fr) Preparation combinee d'acide 2-methylthiazolidine-2,4-dicarboxylique et de paracetamol
RU95101840A (ru) Сложные эфиры циклогексанола и содержащий их фармацевтический препарат

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: S.A. *INPHARZAM

Effective date: 20061112